Amoy Diagnostics Co., Ltd.'s (SZSE:300685) Earnings Haven't Escaped The Attention Of Investors
Sep 18
Have your own idea? Try our Stock Screener
Markets has moved to Discover
You can now access Markets by navigating to Discover and selecting Markets.
Chinese (SSE) Biotech Industry Analysis
UpdatedSep 23, 2024
DataAggregated Company Financials
Companies73
- 7D-0.4%
- 3M-12.1%
- 1Y-29.0%
- YTD-33.9%
The Biotech is pretty flat in the last 7 days, but Beijing Wantai Biological Pharmacy Enterprise has stood out, gaining 4.6%. Unfortunately though, the industry is down 29% over the past 12 months. Looking forward, earnings are forecast to grow by 40% annually.
Industry Valuation and Performance
Has the Chinese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 24 Sep 2024 | CN¥731.6b | CN¥154.1b | CN¥14.5b | 29.7x | 50.6x | 4.7x |
| Thu, 22 Aug 2024 | CN¥784.3b | CN¥161.3b | CN¥17.3b | 28.8x | 45.4x | 4.9x |
| Sat, 20 Jul 2024 | CN¥848.3b | CN¥161.1b | CN¥17.3b | 33.9x | 49x | 5.3x |
| Mon, 17 Jun 2024 | CN¥877.1b | CN¥161.1b | CN¥17.3b | 32.3x | 50.7x | 5.4x |
| Wed, 15 May 2024 | CN¥971.9b | CN¥161.1b | CN¥17.3b | 38.8x | 56.3x | 6x |
| Fri, 12 Apr 2024 | CN¥940.7b | CN¥161.4b | CN¥20.2b | 37.8x | 46.5x | 5.8x |
| Sun, 10 Mar 2024 | CN¥978.7b | CN¥165.5b | CN¥22.1b | 35.6x | 44.3x | 5.9x |
| Tue, 06 Feb 2024 | CN¥834.3b | CN¥167.9b | CN¥21.4b | 28.2x | 38.9x | 5x |
| Thu, 04 Jan 2024 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 39.5x | 51.5x | 6.6x |
| Sat, 02 Dec 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 41.5x | 53.3x | 6.8x |
| Mon, 30 Oct 2023 | CN¥1.1t | CN¥175.3b | CN¥25.0b | 39.6x | 42.4x | 6x |
| Wed, 27 Sep 2023 | CN¥1.0t | CN¥170.9b | CN¥25.2b | 40.9x | 41.2x | 6.1x |
| Fri, 25 Aug 2023 | CN¥983.3b | CN¥172.2b | CN¥28.2b | 36.8x | 34.9x | 5.7x |
| Sun, 23 Jul 2023 | CN¥1.1t | CN¥177.4b | CN¥29.9b | 38.9x | 35.8x | 6x |
| Tue, 20 Jun 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 38.6x | 37.2x | 6.1x |
| Thu, 18 May 2023 | CN¥1.2t | CN¥177.8b | CN¥29.6b | 41.1x | 39.2x | 6.5x |
| Sat, 15 Apr 2023 | CN¥1.3t | CN¥186.6b | CN¥36.5b | 42.4x | 35.5x | 6.9x |
| Mon, 13 Mar 2023 | CN¥1.3t | CN¥179.0b | CN¥36.0b | 43.9x | 35.1x | 7.1x |
| Wed, 08 Feb 2023 | CN¥1.3t | CN¥179.6b | CN¥37.9b | 42.6x | 34.3x | 7.2x |
| Fri, 06 Jan 2023 | CN¥1.3t | CN¥175.6b | CN¥37.9b | 40.3x | 33.3x | 7.2x |
| Sun, 04 Dec 2022 | CN¥1.3t | CN¥175.6b | CN¥37.9b | 38.8x | 33.1x | 7.2x |
| Tue, 01 Nov 2022 | CN¥1.2t | CN¥174.9b | CN¥37.0b | 37.5x | 31.2x | 6.6x |
| Thu, 29 Sep 2022 | CN¥1.1t | CN¥174.0b | CN¥40.1b | 29.9x | 27.9x | 6.4x |
| Sat, 27 Aug 2022 | CN¥1.2t | CN¥219.9b | CN¥44.5b | 31.9x | 27.6x | 5.6x |
| Mon, 25 Jul 2022 | CN¥1.3t | CN¥168.8b | CN¥42.1b | 36.6x | 30.6x | 7.6x |
| Wed, 22 Jun 2022 | CN¥1.3t | CN¥168.1b | CN¥42.4b | 38.7x | 30.6x | 7.7x |
| Fri, 20 May 2022 | CN¥1.2t | CN¥168.1b | CN¥42.4b | 35.3x | 28.4x | 7.2x |
| Sun, 17 Apr 2022 | CN¥1.4t | CN¥153.5b | CN¥40.5b | 38.3x | 33.4x | 8.8x |
| Tue, 15 Mar 2022 | CN¥1.4t | CN¥152.5b | CN¥40.9b | 46.3x | 34.4x | 9.2x |
| Thu, 10 Feb 2022 | CN¥1.4t | CN¥148.5b | CN¥39.7b | 45.1x | 35.7x | 9.5x |
| Sat, 08 Jan 2022 | CN¥1.5t | CN¥143.3b | CN¥39.3b | 48.3x | 37.7x | 10.3x |
| Mon, 06 Dec 2021 | CN¥1.6t | CN¥141.6b | CN¥39.1b | 49.6x | 39.9x | 11x |
| Wed, 03 Nov 2021 | CN¥1.5t | CN¥144.1b | CN¥39.6b | 40.9x | 38.4x | 10.5x |
| Fri, 01 Oct 2021 | CN¥1.6t | CN¥130.3b | CN¥33.4b | 45.3x | 46.7x | 12x |
Price to Earnings Ratio
46.7x
Current Industry PE
- Investors are optimistic on the Chinese Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 50.6x which is higher than its 3-year average PE of 39.3x.
- The 3-year average PS ratio of 7.2x is higher than the industry's current PS ratio of 4.7x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 24% per year over the last three years.
- Meanwhile revenues for these companies have grown 5.8% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 1.05% | |
| Healthcare | -0.77% | |
| Biotech | -0.42% | |
| Biotech | -0.42% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603392 Beijing Wantai Biological Pharmacy Enterprise | CN¥71.13 | 4.6% +CN¥4.0b | 49.7% | PS33.2x | |
| 300896 Imeik Technology DevelopmentLtd | CN¥146.48 | 8.4% +CN¥3.4b | -47.7% | PE21.9x | |
| 300122 Chongqing Zhifei Biological Products | CN¥21.81 | 5.5% +CN¥2.7b | -55.1% | PE8.6x | |
| 002252 Shanghai RAAS Blood Products | CN¥6.81 | 3.8% +CN¥1.7b | -2.4% | PE25.3x | |
| 002007 Hualan Biological Engineering | CN¥14.72 | 6.4% +CN¥1.6b | -33.1% | PE19.3x |
